Evaluation of the Bifurcated Multilayer Flow Modulator for the Treatment of Abdominal Aortic Aneurysm | MicrobiomeTrials← Back to trialsNCT03024554
Evaluation of the Bifurcated Multilayer Flow Modulator for the Treatment of Abdominal Aortic Aneurysm
CompletedNAINTERVENTIONAL
Trial Details
Start: 2014-04-11Est. Completion: 2018-08-07
Enrollment target: 42 participants Locations- Hôpitaux IRIS Sud Molière Longchamps, Brussels, Uccle, Belgium
- City Hospital Clinic, Sofia, Bulgaria
- CMC Coeur et Vaisseaux, Salé, Morocco
- ELYTIS Hospital: Spital Multidisciplinar şi Policlinică, Iași, Romania
- European Hospital Polisano, Sibiu, Romania
- University Medical Centre Ljubljana, Ljubljana, Slovenia
- Maribor University Medical Centre, Maribor, Slovenia
Other microbiome trials you might be interested in
Type II EndoleakAbdominal Aortic Aneurysm Enlargement
Background and rationale:
Abdominal aortic aneurysm (AAA) is a weakening and enlargement of the main artery in the abdo…
Multiple LocationsEst. completion Dec 31, 2027
Aortic Aneurysm, ThoracoabdominalAortic Aneurysm, AbdominalIntraoperative HypotensionHemodynamic Instability During Anesthesia
The purpose of this study is to compare two intravenous anesthetics, remimazolam and propofol, for their effects on intr…
Seoul, South Korea
Est. completion Sep 15, 2027
AAAAAA - Abdominal Aortic Aneurysm
Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVA…
Huntsville, United StatesEst. completion Mar 2032